Prospects for the Prevention and Control of Pseudomonal Infection in Children with Cystic Fibrosis

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.2, Iss.6, 2000-11, pp. : 451-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Control of Malabsorption in Cystic Fibrosis

By Littlewood J.M. Wolfe S.P.

Pediatric Drugs, Vol. 2, Iss. 3, 2000-05 ,pp. : 205-222

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Ibuprofen in Children with Cystic Fibrosis

By Han E.E. Beringer P.M. Louie S.G. Gill M.A. Shapiro B.J.

Clinical Pharmacokinetics, Vol. 43, Iss. 3, 2004-01 ,pp. : 145-156

Adis International

Access to resources Recommend Favorite

Inhalable Antibiotic Nanoformulations for the Treatment of Pseudomonas Aeruginosa Infection in Cystic Fibrosis – A Review

Drug Delivery Letters, Vol. 4, Iss. 3, 2014-12 ,pp. : 193-207

Bentham Science Publishers

Access to resources Recommend Favorite

Peritoneal Dialysis: Prevention and Control of Infection

By Gokal R.

Drugs & Aging, Vol. 17, Iss. 4, 2000-10 ,pp. : 269-282

Adis International

Access to resources Recommend Favorite

Targeting Airway Inflammation in Cystic Fibrosis in Children: Past, Present, and Future

By Pressler Tacjana

Pediatric Drugs, Vol. 13, Iss. 3, 2011-06 ,pp. : 141-147

Adis International

Access to resources Recommend Favorite